Weight Gain Risk Factor assessment checklist: overview and recommendation for use

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Patients with mental illness often experience weight gain, a significant side effect of antipsychotic medications.
• Early identification of risk factors is crucial for managing weight gain and improving patient outcomes.

Purpose of the Study:

• To introduce the 16-item Weight Gain Risk Factor (WGRF-16) checklist for assessing weight gain risk in patients undergoing antipsychotic treatment.
• To provide a brief, evidence-based tool for early risk assessment and intervention.

Main Methods:

• The WGRF-16 checklist comprises 16 items based on published research of weight gain predictors.
• Factors include demographics, clinical characteristics, lifestyle, and treatment response.
• The checklist is designed for repeated assessment early in antipsychotic treatment.

Main Results:

• The WGRF-16 includes factors such as age, BMI, diagnosis, appetite, and physical activity.
• It aims to predict clinically significant weight gain (>7%) during long-term antipsychotic therapy.
• Further research is needed to validate its predictive accuracy.

Conclusions:

• The WGRF-16 checklist serves as a supplementary tool for weight monitoring in patients with severe mental disorders.
• It facilitates clinical decision-making alongside existing guidelines.
• It is not a replacement for comprehensive patient monitoring.